Paula Ragan, President and CEO at X4 Pharmaceuticals, Inc (XFOR), sold 438,968 shares at $0.73 ($327K) on 2023-11-01, disclosed to the SEC on 2023-11-03.
Scheduled sale ($327k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.73 | 199,531 | $146K | 44.5% |
| 2 | $0.73 | 199,531 | $146K | 44.5% |
| 3 | $0.90 | 39,906 | $36K | 11.0% |
| Total | $0.75 avg | 438,968 | $327K | 100% |
| Filing → |
| XFOR | SELL | 2024-10-16 | $18K | — | Filing → |
| XFOR | SELL | 2024-10-08 | $263K | — | Filing → |
| XFOR | SELL | 2024-03-11 | $44K | — | Filing → |